🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Association between Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Use and Primary Open-Angle Glaucoma Risk in All of Us

Ophthalmology(2025)10.1016/j.ophtha.2025.06.014Source: DataRank Database

Association between Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Use and Primary Open-Angle Glaucoma Risk in All of Us is a dataset published in Ophthalmology (2025). On theSindex it has a DataRank of 0.104, placing it in the top 77.8% of the data-sharing corpus. It has been cited 1 time, with 1 citing works in its 1-hop citation network.

Top 78%percentile

0.104DataRank

Ranks in the top 78% for downstream scientific impact

Data paper Open Access1 citations · 1 citing works in its network

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (32 grants)Impact (FWCI 0.92)OA: hybridTopics (52)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (1/3)

Dataset classification

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

0

From 0 citing papers with measurable signal

This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.

Learn more about DataRank methodology →

Authors (7)

Fangming Jin,Roy Lee ORCID,Isabel Di Rosa,Rebecca Salowe,Gui‐Shuang Ying ORCID

Live enrichment

PubMed:40550363 PMC:PMC12453943 OpenAlex:https://openalex.org/W4411507441

Genome Center, University of California, Davis

Grant: OT2 OD002750

Genome Center, University of California, Davis

Grant: OT2 OD023206

Genome Center, University of California, Davis

Grant: U24 OD023163

Genome Center, University of California, Davis

Grant: OT2 OD025315

Genome Center, University of California, Davis

Grant: U24 OD023176

Genome Center, University of California, Davis

Grant: OT2 OD025337

Genome Center, University of California, Davis

Grant: OT2 OD002748

Genome Center, University of California, Davis

Grant: OT2 OD023205

Genome Center, University of California, Davis

Grant: OT2 OD002751

Genome Center, University of California, Davis

Grant: OT2 OD025276

Genome Center, University of California, Davis

Grant: U24 OD023121

Genome Center, University of California, Davis

Grant: OT2 OD025277

Office of the Director

Grant: AOD 16037

Office of the Director

Grant: OT2 OD026550

Office of the Director

Grant: OT2 OD026554

Office of the Director

Grant: OT2 OD026551

Office of the Director

Grant: OT2 OD 026552

Office of the Director

Grant: OT2 OD026549

Office of the Director

Grant: OT2 OD026553

Office of the Director

Grant: OT2 OD026548

Office of the Director

Grant: OT2 OD026556

Office of the Director

Grant: OT2 OD026557

Office of the Director

Grant: OT2 OD026555

National Eye Institute

Grant: 1R01EY023557

National Eye Institute

Grant: P30 EY001583

National Institute of Child Health and Human Development

Grant: F30HD114405

NIH HHS

Grant: U2C OD023196

NEI NIH HHS

Grant: R01 EY023557

Paul Mackall and Evanina Bell Mackall Trust

Research to Prevent Blindness

FM Kirby Foundation

National Institutes of Health

FWCI

0.92

Citation Percentile

0.7%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.ophtha.2025.06.014

publisherhttps://doi.org/10.1016/j.ophtha.2025.06.014

publisherhttps://api.elsevier.com/content/article/PII:S0161642025003847?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0161642025003847?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40550363

Fields of Study

Retinal Diseases and TreatmentsGlaucoma and retinal disordersOphthalmology and Visual Impairment StudiesHumansGlaucoma, Open-AngleMaleFemaleMiddle AgedRetrospective StudiesUnited StatesAdultReverse Transcriptase InhibitorsRisk FactorsElectronic Health RecordsAgedNucleosidesIntraocular PressurePropensity ScoreHIV Infections

MeSH Terms

AdultAgedFemaleGlaucoma, Open-AngleHumansIntraocular PressureMaleMiddle AgedNucleosidesRetrospective StudiesRisk FactorsUnited StatesHIV InfectionsReverse Transcriptase InhibitorsPropensity ScoreElectronic Health Records

Keywords

MedicineReverse transcriptaseOpen angle glaucomaNucleoside Reverse Transcriptase InhibitorNucleotideAssociation (psychology)GlaucomaOphthalmologyHuman immunodeficiency virus (HIV)VirologyGeneticsPolymerase chain reactionAntiretroviral therapyGeneBiologyPrimary Open-angle GlaucomaAll Of Us, Nucleoside And Nucleotide Reverse Transcriptase Inhibitors

Sustainable Development Goals

SDG 0: Zero hunger